Personal information

Netherlands

Activities

Employment (1)

Franciscus Gasthuis en Vlietland: Rotterdam, Zuid-Holland, NL

2022 to present | Resident Internal Medicine
Employment
Source: Self-asserted source
David Cucchi

Education and qualifications (2)

VU Amsterdam: Amsterdam, Noord-Holland, NL

2021-11-16 | PhD
Education
Source: Self-asserted source
David Cucchi

VU University: Amsterdam, NL

2011 to 2018 | MD
Qualification
Source: Self-asserted source
David Cucchi

Funding (4)

Award for best pre-clinical thesis 2021

Award
Cancer Center Amsterdam (Amsterdam, NL)
Source: Self-asserted source
David Cucchi

Master research internship Washington University in St. Louis, USA

Award
Nijbakker Morra Stichting (Amsterdam, NL)
Source: Self-asserted source
David Cucchi

Visiting Scholarship

Grant
Prins Bernhard Cultuurfonds (Amsterdam, NL)
Source: Self-asserted source
David Cucchi

Visiting Scholarship Washington University in St. Louis

Grant
KWF Kankerbestrijding (Amsterdam, NL)
Source: Self-asserted source
David Cucchi

Works (29)

Quality of Life Gains in Frail and Intermediate-Fit Patients with Multiple Myeloma: Findings from the Prospective Hovon123 Clinical Trial

SSRN
2024 | Other
EID:

2-s2.0-85186373237

Part of ISSN: 15565068
Contributors: Seefat, M.R.; Stege, C.A.M.; Lissenberg-Witte, B.I.; Levin, M.-D.; Timmers, G.-J.; Hoogendoorn, M.; Ypma, P.F.; Klein, S.K.; Velders, G.A.; Westerman, M. et al.
Source: Self-asserted source
David Cucchi via Scopus - Elsevier

Treatment sequences and drug costs from diagnosis to death in multiple myeloma

European Journal of Haematology
2024 | Journal article
EID:

2-s2.0-85173688771

Part of ISSN: 16000609 09024441
Contributors: Seefat, M.R.; Cucchi, D.G.J.; Groen, K.; Donker, M.L.; van der Hem, K.G.; Westerman, M.; Gerrits, A.M.; Beeker, A.; van de Donk, N.W.C.J.; Blommestein, H.M. et al.
Source: Self-asserted source
David Cucchi via Scopus - Elsevier
grade
Preferred source (of 2)‎

Quality of life gains in frail and intermediate-fit patients with multiple Myeloma: Findings from the prospective HOVON123 clinical trial.

European journal of cancer (Oxford, England : 1990)
2024-06-06 | Journal article
Contributors: Seefat MR; Stege CAM; Lissenberg-Witte BI; Levin MD; Timmers GJ; Hoogendoorn M; Ypma PF; Klein SK; Velders GA; Westerman M et al.
Source: Self-asserted source
David Cucchi
grade
Preferred source (of 2)‎

Acute perimyocarditis associated with Bartonella henselae infection

BMJ Case Reports
2023 | Journal article
EID:

2-s2.0-85177678112

Part of ISSN: 1757790X
Contributors: Cucchi, D.G.J.; Govers, A.; Janse, F.H.; Van Dalen, B.M.
Source: Self-asserted source
David Cucchi via Scopus - Elsevier
grade
Preferred source (of 2)‎

Equality: trial and error?

Blood
2023 | Journal article
EID:

2-s2.0-85165041689

Part of ISSN: 15280020 00064971
Contributors: Cucchi, D.G.J.; Zweegman, S.
Source: Self-asserted source
David Cucchi via Scopus - Elsevier
grade
Preferred source (of 2)‎

Replay to the Comment on Association of FLT3-internal tandem duplication length with overall survival in acute myeloid leukemia: a systematic review and meta-analysis

Haematologica
2023 | Journal article
EID:

2-s2.0-85149154328

Part of ISSN: 15928721 03906078
Contributors: Polak, T.B.; Janssen, J.J.W.M.; Cucchi, D.G.J.
Source: Self-asserted source
David Cucchi via Scopus - Elsevier
grade
Preferred source (of 2)‎

Results from Expanded Access Programs: A Review of Academic Literature

Drugs
2023 | Journal article
EID:

2-s2.0-85159719414

Part of ISSN: 11791950 00126667
Contributors: Polak, T.B.; Cucchi, D.G.J.; Schelhaas, J.; Ahmed, S.S.; Khoshnaw, N.; van Rosmalen, J.; Uyl-de Groot, C.A.
Source: Self-asserted source
David Cucchi via Scopus - Elsevier
grade
Preferred source (of 2)‎

Association of FLT3-ITD length with overall survival in acute myeloid leukemia: a systematic review and meta-analysis.

Haematologica
2022-07-07 | Journal article
Source: Self-asserted source
David Cucchi
grade
Preferred source (of 2)‎

The DRUG Access Protocol: access inequality and European harmonisation

The Lancet Oncology
2022-05 | Journal article
Part of ISSN: 1470-2045
Source: Self-asserted source
David Cucchi
grade
Preferred source (of 2)‎

Generating Evidence from Expanded Access Use of Rare Disease Medicines: Challenges and Recommendations

Frontiers in Pharmacology
2022-05-23 | Journal article
Part of ISSN: 1663-9812
Source: Self-asserted source
David Cucchi
grade
Preferred source (of 2)‎

Incremental benefits of novel pharmaceuticals in the UK: a cross-sectional analysis of NICE technology appraisals from 2010 to 2020

BMJ Open
2022-04-08 | Journal article
Part of ISSN: 2044-6055
Part of ISSN: 2044-6055
Source: Self-asserted source
David Cucchi
grade
Preferred source (of 3)‎

The predictive value of a positive phase II ASH abstract for peer-reviewed publication and progression to phase III

Blood
2022-01-12 | Journal article
Part of ISSN: 0006-4971
Part of ISSN: 1528-0020
Source: Self-asserted source
David Cucchi
grade
Preferred source (of 3)‎

Real-world data from expanded access programmes in health technology assessments: a review of NICE technology appraisals

BMJ Open
2022-01-06 | Journal article
Part of ISSN: 2044-6055
Part of ISSN: 2044-6055
Source: Self-asserted source
David Cucchi
grade
Preferred source (of 3)‎

Expanded Access in The Netherlands: prescribing unregistered medicine,Behandeling met een niet-geregistreerd geneesmiddel

Nederlands tijdschrift voor geneeskunde
2021 | Journal article
EID:

2-s2.0-85102602306

Part of ISSN: 18768784
Contributors: Polak, T.B.; Cucchi, D.G.J.; van Rosmalen, J.
Source: Self-asserted source
David Cucchi via Scopus - Elsevier

Treatment with an unregistered medicine: The use of 'expanded access' in the Netherlands,Behandeling met een niet-geregistreerd geneesmiddel

Nederlands Tijdschrift voor Geneeskunde
2021 | Journal article
EID:

2-s2.0-85102116080

Part of ISSN: 00282162
Contributors: Polak, T.B.; Cucchi, D.G.J.; Van Rosmalen, J.
Source: Self-asserted source
David Cucchi via Scopus - Elsevier

A Systematic Review of Cost-Effectiveness Analyses of Novel Agents in the Treatment of Multiple Myeloma

Cancers
2021-11-09 | Journal article
Part of ISSN: 2072-6694
Source: Self-asserted source
David Cucchi
grade
Preferred source (of 4)‎

DNA vs cDNA FLT3-ITD allelic ratio and length measurements in adult acute myeloid leukemia.

Blood advances
2021-11-01 | Journal article
Source: Self-asserted source
David Cucchi
grade
Preferred source (of 3)‎

The wider perspective: twenty years of clinical trials in myelodysplastic syndromes

British Journal of Haematology
2021-10-10 | Journal article
Source: Self-asserted source
David Cucchi
grade
Preferred source (of 3)‎

Phosphoproteomic Characterization of Primary AML Samples and Relevance for Response Toward FLT3-inhibitors.

HemaSphere
2021-06-12 | Journal article
Source: Self-asserted source
David Cucchi
grade
Preferred source (of 2)‎

[Expanded Access in The Netherlands: prescribing unregistered medicine].

Nederlands tijdschrift voor geneeskunde
2021-02-25 | Journal article
Source: Self-asserted source
David Cucchi

Two decades of targeted therapies in acute myeloid leukemia.

Leukemia
2021-02-15 | Journal article
Source: Self-asserted source
David Cucchi
grade
Preferred source (of 3)‎

The influence of delay in mononuclear cell isolation on acute myeloid leukemia phosphorylation profiles.

Journal of proteomics
2021-02-06 | Journal article
Source: Self-asserted source
David Cucchi
grade
Preferred source (of 2)‎

Harnessing gene expression profiles for the identification of ex vivo drug response genes in pediatric acute myeloid leukemia

Cancers
2020 | Journal article
EID:

2-s2.0-85085090923

Part of ISSN: 20726694
Contributors: Cucchi, D.G.J.; Bachas, C.; van den Heuvel-Eibrink, M.M.; Arentsen-Peters, S.T.C.J.M.; Kwidama, Z.J.; Schuurhuis, G.J.; Assaraf, Y.G.; de Haas, V.; Kaspers, G.J.L.; Cloos, J.
Source: Self-asserted source
David Cucchi via Scopus - Elsevier
grade
Preferred source (of 2)‎

TP53 mutations and relevance of expression of TP53 pathway genes in paediatric acute myeloid leukaemia

British Journal of Haematology
2020 | Journal article
EID:

2-s2.0-85073975759

Part of ISBN:

13652141 00071048

Contributors: Cucchi, D.G.J.; Bachas, C.; Klein, K.; Huttenhuis, S.; Zwaan, C.M.; Ossenkoppele, G.J.; Janssen, J.M.W.M.; Kaspers, G.L.; Cloos, J.
Source: Self-asserted source
David Cucchi via Scopus - Elsevier
grade
Preferred source (of 2)‎

Ex vivo cultures and drug testing of primary acute myeloid leukemia samples: Current techniques and implications for experimental design and outcome

Drug Resistance Updates
2020-12 | Journal article
Part of ISSN: 1368-7646
Source: Self-asserted source
David Cucchi
grade
Preferred source (of 2)‎

Phosphotyrosine-based Phosphoproteomics for Target Identification and Drug Response Prediction in AML Cell Lines

Molecular & Cellular Proteomics
2020-02 | Journal article
Part of ISSN: 1535-9476
Contributors: Carolien van Alphen; Jacqueline Cloos; Robin Beekhof; David G. J. Cucchi; Sander R. Piersma; Jaco C. Knol; Alex A. Henneman; Thang V. Pham; Johan van Meerloo; Gert J. Ossenkoppele et al.
Source: Self-asserted source
David Cucchi via Crossref Metadata Search
grade
Preferred source (of 2)‎

RNA-based FLT3-ITD allelic ratio is associated with outcome and ex vivo response to FLT3 inhibitors in pediatric AML

Blood
2018 | Journal article
EID:

2-s2.0-85048150537

Part of ISBN:

15280020 00064971

Contributors: Cucchi, D.G.J.; Denys, B.; Kaspers, G.J.L.; Janssen, J.J.W.M.; Ossenkoppele, G.J.; Haas, V.D.; Zwaan, C.M.; van den Heuvel-Eibrink, M.M.; Philippe, J.; Csikós, T. et al.
Source: Self-asserted source
David Cucchi via Scopus - Elsevier

Phosphatase Sequencing of Pediatric Acute Myeloid Leukemia Reveals a Novel Mutation in the Phosphatase Gene PTPN4

Journal of Molecular and Clinical Medicine
2018-01-20 | Journal article
Part of ISSN: 2616-3632
Part of ISSN: 2617-5282
Source: Self-asserted source
David Cucchi

Relevance of leukemic stem cells in acute myeloid leukemia: Heterogeneity and influence on disease monitoring, prognosis and treatment design

Expert Review of Hematology
2014 | Journal article
EID:

2-s2.0-84911456464

Part of ISBN:

17474094 17474086

Contributors: Wouters, R.; Cucchi, D.; Kaspers, G.J.L.; Schuurhuis, G.J.; Cloos, J.
Source: Self-asserted source
David Cucchi via Scopus - Elsevier